Lv2
160 积分 2023-10-16 加入
Sieve Maximum Likelihood Estimation of Partially Linear Transformation Models With Interval‐Censored Data
21小时前
已完结
Tensor Landmark Analysis With Application to ADNI data
4天前
已完结
Modified isotonic regression based phase I/II clinical trial design identifying optimal biological dose
4天前
已完结
Mixture Cure Semiparametric Accelerated Failure Time Models With Partly Interval‐Censored Data
7天前
已完结
Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug
7天前
已完结
Balance Index to Determine the Follow‐Up Duration of Oncology Trials
8天前
已完结
Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule
9天前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
11天前
已完结
Empirical Sandwich Variance Estimator for Iterated Conditional Expectation g‐Computation
11天前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
11天前
已完结
皖公网安备34019202002308
